Search | Clinical Trials Finder

Conditions: PTSD, Chronic Pain
Interventions: Yoga; Behavioral
Lead sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Alcohol Related Morbidity, Alcohol Dependence
Interventions: Brief Motivational Intervention, Assessment and list of resources, Referral to Community Resources; Behavioral
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 14 Years to 21 Years
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Ulcerative Colitis
Interventions: Filgotinib, PTM filgotinib; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,351 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 61
States / cities: Dothan, Alabama • Scottsdale, Arizona • Long Beach, California + 53 more

Conditions: Marfan Syndrome
Interventions: Exercise Intervention Group; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 12 Years to 21 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Rheumatoid Arthritis (RA)
Interventions: ABBV-154, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 473 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 101
States / cities: Phoenix, Arizona • Jonesboro, Arkansas • Fullerton, California + 89 more

Conditions: Age-related Macular Degeneration
Interventions: Ranibizumab; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 1,097 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 99
States / cities: Phoenix, Arizona • Tucson, Arizona • Arcadia, California + 91 more

Conditions: Ulcerative Colitis, FMT, Fecal Microbiota Transplant
Interventions: Metronidazole, Placebo, Vancomycin, Fecal Microbiota Transplantation; Drug · Biological
Lead sponsor: Ari M Grinspan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy, Overweight and Obesity
Interventions: Exercise Modes; Behavioral
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Systemic Lupus Erythematosus
Interventions: Cenerimod 0.5 mg, Cenerimod 1 mg, Cenerimod 2 mg, Cenerimod 4 mg, Placebo, cenerimod 2 mg (ex-4 mg); Drug
Lead sponsor: Viatris Innovation GmbH; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 29
States / cities: Anniston, Alabama • La Jolla, California • Los Alamitos, California + 25 more

Conditions: Lifestyle-related Condition, Obesity, Sedentary Lifestyle, PreDiabetes, Hypertension
Interventions: Health Coaching; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 64 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Anemia, Red Blood Cell Transfusion, Fatigability, Fatigue, Physical Function
Interventions: Red blood cell transfusion; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acne Vulgaris
Interventions: Feedback group, Non Feedback group; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 15 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Multiple Sclerosis
Interventions: BIIB033 (opicinumab), Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 58 Years
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 51
States / cities: Cullman, Alabama • Gilbert, Arizona • Berkeley, California + 44 more

Conditions: Obesity
Interventions: Diet and Exercise, Diet and Exercise-Delayed; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Years to 55 Years
Enrollment: 310 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Musculoskeletal Strain, Musculoskeletal Sprain, Injury of Musculoskeletal System
Interventions: Computer based pain management; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Baltimore, Maryland • Nashville, Tennessee

Conditions: Ulcerative Colitis
Interventions: Etrozulimab, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 609 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 38
States / cities: Birmingham, Alabama • La Jolla, California • San Diego, California + 32 more

Conditions: Arthritis, Juvenile
Interventions: Ren-Ex Machine, Dual-Emission X-ray Absorptiometry (DEXA) scan, Biodex dynamometer, Sub-maximal test, Quality of life questionnaires; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 10 Years to 21 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hemophilia A
Interventions: GreenGene™ F and an approved recombinant Factor VIII product, GreenGene™ F; Biological
Lead sponsor: Green Cross Corporation; Industry
Eligibility: 12 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 10
States / cities: Little Rock, Arkansas • Los Angeles, California • Torrance, California + 7 more

Conditions: Obesity
Interventions: Behavioral weight loss intervention (Online; Rx Weight Loss), Minority stress intervention, Social support intervention, Negative body image intervention; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Chronic Conditions, Multiple, Chronic Conditions, Food Insecurity, Low-Income Population
Interventions: Grocery Support Monthly Program, Grocery Support One-Time Payment; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 6,975 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Rheumatoid Arthritis
Interventions: GLPG0634, Placebo; Drug
Lead sponsor: Lakefront Biotherapeutics NV; Industry
Eligibility: 18 Years and older
Enrollment: 599 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 28
States / cities: Huntsville, Alabama • Gilbert, Arizona • Phoenix, Arizona + 25 more

Conditions: Muscular Weakness
Interventions: Short foot exercise protocol, Short foot exercise plus NMES; Other
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Knee Osteoarthritis
Interventions: Exercise Program, Mindful Exercise; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 50 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lymphoblastic Leukemia, Cancer Survivors, Aplastic Anemia, Myelodysplastic Syndromes, Myeloid Leukemia
Interventions: Nicotinamide Riboside, Placebo, Exercise Intervention; Dietary Supplement · Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 10 Years to 30 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Duarte, California • Philadelphia, Pennsylvania • Memphis, Tennessee

Search by objective public record fields.

Feasibility and Efficacy of A Yoga Intervention for Comorbid Chronic Pain and PTSD

Project RAP: Reaching Adolescents for Prevention

Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

Marfan Syndrome Moderate Exercise Pilot

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)

Pregnancy Exercise Mode Effect on Childhood Obesity

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

MyLife: A Digital Health Coaching Program

A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)

Re-energize With Nutrition, Exercise and Weight Loss

Pain Management Following Musculoskeletal Injury

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

Exercise and Body Composition in Juvenile Idiopathic Arthritis

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Optimizing an Online Behavioral Weight Loss Intervention and Novel Culturally Tailored Components for Sexual Minority Women

Evaluating Covered California's Grocery Support Program

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Training Intrinsic Foot Muscles

Telehealth Exercise and Mindfulness for Pain in Osteoarthritis - Stage 1B

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors